Top Links

Articles Related to therapies

Economic Prospects in the Production of Bee Venom and Bee Venom Products from the Aspect of Application in Medical and Cosmetological Therapies

View complete article: PDF  |  Full-text

Equines as Tools Vs Partners: A Critical Look at the Uses and Beliefs Surrounding Horses in Equine Therapies and Argument for Mechanical Horses

Horses have their own unique status as therapy animals due to their function in both physical and psychotherapies. Current models of Equine Assisted Activities and Therapies (EAAT) utilize horses for a range of physical, psychological and learning therapies to benefit humans, often referring to horses as therapeutic “partners”. To fulfill certification requirements for existing models of EAAT, practitioners are required to study equine behavior through the belief systems currently modeled in the natural horsemanship community. Despite requiring knowledge in horse behavior, studies and anecdotal evidence suggests that horses used in EAAT commonly display confusion or escape behaviors, “burn out” and/or display signs of depression. These behaviors could be a result of contradictions in the interpretation of equine behavior within the natural horsemanship practices or a lack of understanding and utilization of equine learning theory within the context of EAAT.
View complete article: PDF  |  Full-text

Potentials, Limitations and Future Directions of MR Contrast Media in Ablation Therapies

ImagingIntroductionMR contrast media have become an indispensable part of magnetic resonance (MR) imaging, but their roles in ablation therapies are still controversial. The interactions between physical/biological properties of MR contrast media (Longitudinal=T1, transverse=T2 and susceptibility=T2* relaxation times) and diseased tissues (perfusion, edema, hemorrhage and coagulative necrosis) play important roles in differentiating pathologic and ablated tissues.
View complete article: PDF  |  Full-text

Perspectives and Potential Applications of Ruthenium-Based Nanocarriers for Cancer Therapy

Cancer is a highly heterogeneous disease characterised by continuous uncontrolled growth and expansion of abnormal cells. In general, in tumor cells the signalling pathways regulating cellular processes, as cell growth and division and cell to cellcommunication result strongly altered.
View complete article: PDF  |  Full-text  | Digital
 
 


Editorial Board Members Related to therapies

Zhiyuan Li

Professor
Laboratory of Ion Channels Research
Guangzhou Institute of Biomedicine and Health
Chinese Academy of Sciences
China

Henry Lawrence Dorkin

Associate Professor of Pediatrics
Harvard Medical School
Harvard University
United Stated

Jonathan Scott Harrison

Professor
Division of Hematology/Medical Oncology University of Missouri
United States

Martin Michaelis

Professor of Molecular Medicine
Centre for Molecular Processing and School of Biosciences
University of Kent
United Kingdom

ADRIAN M. BARANCHUK

Associate Professor
Department of Biomedical and Molecular Sciences
Queen’s University
Canada

RICHARD G. MOORE

Professor
Department of Obstetrics and Gynecology
Warren Alpert Medical School
Brown University
United States

Ali Nsair

Assistant Professor
Division of Cardiology
David Geffen School of Medicine
United States

CHIA-YI KUAN

Associate Professor
Department of Pediatrics
Center for Neurodegenerative Disease
Emory University School of Medicine
United States

Eugene S. Kim

Associate Professor
Department of Surgery
University of Southern California
United States

Saima Riazuddin

Associate Professor
Department of Otolaryngology-Head & Neck Surgery
School of Medicine
University of Maryland
United States
Submit Manuscript